First comprehensive report of impact of genomic alterations, chemotherapy, targeted therapy and immunotherapy on outcomes in the genomics driven squamous master protocol LungMAP.
Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Vassiliki Papadimitrakopoulou, Mary Weber Redman, David R. Gandara, Fred R. Hirsch, Philip C. Mack, Corey J. Langer, Martin J. Edelman, Charu Aggarwal, Mark A. Socinski, Scott N. Gettinger, Saiama Naheed Waqar, Katie Griffin, Natasha B. Leighl, Taofeek Kunle Owonikoko, Jeffrey D. Bradley, Suresh S. Ramalingam, Tom Stinchcombe, Charles David Blanke, Karen Kelly, Roy S. Herbst
Institutions: The University of Texas MD Anderson Cancer Center, Fred Hutch Cancer Center, University of California, Davis, University of Colorado Cancer Center, UC Davis Comprehensive Cancer Center, University of Pennsylvania, Fox Chase Cancer Center, Abramson Cancer Center, Florida Hospital Cancer Institute, Yale New Haven Hospital, Yale Cancer Center, Washington University in St. Louis, Princess Margaret Cancer Centre, Emory University, Winship Cancer Institute, University of North Carolina at Chapel Hill, Oregon Health & Science University, Yale University
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2889665012